Here’s how they compare:
Total revenue: $263.6million (+5 percent)
Musculoskeletal solutions: $234.2 million (+1.7 percent)
Enabling technologies: $29.4 million (+41.7 percent)
Total revenue: $1.3 billion (-3.1 percent)
Total orthopedic sales: $530 million (-4.9 percent)
Hips: $149 million (-7.7 percent)
Knees: $223 million (-1.3 percent)
Other reconstruction: $23 million (+6 percent)
Trauma and extremities: $135 million (-8.9 percent)
Total revenue: $233.4 million (-11.5 percent)
Spine: $115.2 million (-19.6 percent)
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
